Eric Curtis
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Eric Curtis
Earlier roles on record: COO at Windtree Therapeutics Inc /De/ (WINT) until January 5, 2026. Windtree Therapeutics Inc /De/ reported in an 8-K filed January 7, 2026 that Eric Curtis resigned as President and Chief Operating Officer, effective January 5, 2026. The proxy statement of Windtree Therapeutics Inc /De/ reports total compensation of $451,727 for Eric Curtis in fiscal 2023, including a base salary of $401,400. Disclosed compensation is on record for 4 fiscal years.
“On January 5, 2026, Eric L. Curtis resigned as President and Chief Operating Officer of Windtree Therapeutics, Inc., effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2026-01-05
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Windtree Therapeutics Inc /De/ (WINT) | Senior Vice President and COO | $401,400 | $451,727 |
| 2022 | Windtree Therapeutics Inc /De/ (WINT) | Senior Vice President and COO | — | — |
| 2020 | Windtree Therapeutics Inc /De/ (WINT) | Senior VP and Chief Operating Officer | $308,333 | $1,756,677 |
| 2019 | Windtree Therapeutics Inc /De/ (WINT) | Senior VP and Chief Operating Officer | — | — |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.